CultureInnovationPatient Engagement

What happens when you let patients design the clinic? (#hcbiz 20)

There’s a lot of pressure being applied to the healthcare industry today. There are penalties for readmissions within 30-days of discharge, reduced (or non) reimbursement for harm due to clinical error (i.e. the CMS “never events”) plus many programs that tie reimbursement to measurable patient outcomes and patient satisfaction (i.e. the HCAHPS survey). One approach to addressing these issues

Innovation

Digital Health: Snake oil or the free market doing its work? (#hcbiz 19)

American Medical Association CEO Dr. James Madara took some shots at digital health at the AMA annual meeting in Chicago last week. He said: “Today we have really remarkable tools — robotic surgery, new forms of radiation treatment, targeted biologics; and we live in a time of rapid development in the digital world — telemedicine as an example.

CultureInnovationPolicy

Regulation, innovation and cords that are too damn short (#hcbiz 18)

Two John Halamka posts caught my attention this week: Making a Difference and A Time of Uncertainty. Both posts ponder where the next round of innovations will come from. Given the ever-changing regulatory landscape in healthcare and the creation of many new Alternative Payment Models (APM), I agree that incumbent vendors and provider organizations will

CMSMACRAPolicy

MACRA and the Creeping Narrative of Healthcare Reform (#hcbiz 17)

The deadline for public comment on the MACRA proposed rule is June 27, 2016 at 11:59 PM ET.  This is the most comprehensive healthcare legislation enacted since Obamacare (ACA) and it will have a significant impact on all actors within our healthcare system for years to come. Since commercial payers tend to take CMS’ lead,